https://www.mondialnews.com/2026/04/20/lenz-therapeutics-advances-presbyopia-treatment-with-groundbreaking-vizz-marketing-application-in-the-uk/
LENZ Therapeutics has officially submitted a Marketing Authorization Application (MAA) to the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) for its innovative drug VIZZ®. Designed to treat presbyopia, a common age-related condition that impairs near vision, VIZZ® represents a promising advancement in eye care. This regulatory milestone marks a significant step forward for LENZ Therapeutics as it seeks approval to bring the treatment to patients across the UK, potentially offering a new non-invasive option for millions affected by presbyopia.
LENZ Therapeutics Advances Presbyopia Treatment with VIZZ Submission to UK Regulatory Authority
LENZ Therapeutics has taken a significant step forward in expanding access to its innovative treatment for presbyopia by submitting a Marketing Authorization Application (MAA) to the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). This submission marks a crucial milestone in the company’s mission to…
—-
Author : Miles Cooper
Publish date : 2026-04-20 18:39:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8
